Latest Breaking News On - Non hodgkin lymphoma - Page 9 : comparemela.com

Three early-phase clinical studies show promising initial data for patients with lymphoma, gastric cancers

Three early-phase clinical studies presented by researchers from The University of Texas MD Anderson Cancer Center at the American Association for Cancer Research (AACR) Annual Meeting 2024 show promising initial data for patients with lymphoma, gastric or gastroesophageal junction cancers, and specific molecularly selected tumors.

United statesKlus pharmaJordi rodonTimothy yapMerck coDevelopment agreementAndrew sabin family fellowship programAmerican association for cancer researchUniversity of texas md anderson cancer centerExperimental therapeutics clinical trials networkBristol myers squibb companyNational cancer institute therapy evaluation programNational cancer instituteAstrazeneca pharmaceuticalsNational institutes of healthManderson cancer

ACE inhibitors show no benefit in reducing chemotherapy-induced heart damage

Patients who took an angiotensin-converting enzyme (ACE) inhibitor while undergoing cancer treatment with high-dose anthracycline chemotherapy did not show any difference in troponin T levels, a biomarker associated with heart damage, at one month after their last chemotherapy dose compared with those who did not take an ACE inhibitor, according to a study presented at the American College of Cardiology's Annual Scientific Session.

Redcar and clevelandUnited kingdomDavid austinAmerican college of cardiologyCare researchAmerican college of cardiology annual scientific sessionNational institute for healthJames cook university hospitalAmerican collegeAnnual scientificSouth teesNational instituteAce inhibitorsBreast cancerCancer treatmentHeart failure

Buxton daughter and dad s sponsored walk for blood cancer raises £1,500

Buxton daughter and dad s sponsored walk for blood cancer raises £1,500
buxtonadvertiser.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from buxtonadvertiser.co.uk Daily Mail and Mail on Sunday newspapers.

United kingdomNeil forsytheChloe forsytheNon hodgkin lymphomaWalk of lightMonsal trailBlood cancerMonsal trail photoBlood cancer united

Theralase Technologies Inc : Theralase Granted Canadian Cancer Vaccine Patent

Theralase Technologies Inc : Theralase Granted Canadian Cancer Vaccine Patent
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesDennis riedlKristina hacheyArkady mandelRoger dumoulin whiteTheralase technologies incCompany photo dynamic compoundsRegulation services providerTechnologies incA european unionVenture exchangeAmerican cancer societyPhoto dynamic compoundsContaining cancer cells inactivatedPhotodynamic treatmentMetal based coordination complexes

Theralase(R) Granted Canadian Cancer Vaccine Patent

TORONTO, ON / ACCESSWIRE / April 5, 2024 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research and development of light and/or radiation activated Photo Dynamic Compounds ("PDCs") for the.

United statesKristina hacheyRoger dumoulin whiteArkady mandelAmerican cancer societyRegulation services providerTheralase technologies incA european unionCompany photo dynamic compoundsTechnologies incVenture exchangePhoto dynamic compoundsContaining cancer cells inactivatedPhotodynamic treatmentMetal based coordination complexesEuropean union